VC-backed Trieza Therapeutics appoints chief scientific officer
Cambridge, Massachusetts-based Trieza Therapeutics Inc, a biotech company focused on cancer immunotherapy, has named Dr. Jeno Gyuris as chief scientific officer. Gyuris is a former chief scientific officer at Aveo Pharmaceuticals. Trieza's backers include MPM Capital, Interwest Partners and Astellas Venture Management LLC.
5 January 2018•2 mins read
